Advertisement

Treatment of Therapy-Resistant Depression with Drip Infusions

  • Paul Kielholz

Abstract

Studies carried out in various countries have repeatedly shown that, when patients suffering from endogenous or psychogenic depression are given oral treatment with antidepressants in combination with psychotherapy, 60–70% of them already show an encouraging response within two weeks, A further 10–15% respond to antidepressive medication when switched to another antidepressant with a suitable activity profile. Approximately 15%, however, fail to improve under oral medication combined with psychotherapy and must therefore be regarded as therapy-resistant cases.

Keywords

Biogenic Amine Infusion Treatment Drip Infusion Endogenous Depression Transmitter Substance 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Angst, J., Insidon als Antidepressivum: Uergleich mit Tofranil; Katamnesen. Nervenarzt 34, 76, 1963PubMedGoogle Scholar
  2. 2.
    Åsberg, M., Thorén, P., Träskman, L., Bertilsson, L., Ringberger, V., “Serotonin depression” —a biochemical subgroup within the affective disorders? Science 191, 478, 1976PubMedCrossRefGoogle Scholar
  3. 3.
    Dilling, H., Weyerer, S., Enders, I., Patienten mit psychischen Storungen in der Allgemeinpraxis und ihre psychiatrische Ueber- weisungsbedurftigkeit. In Häfner, H. (Ed.): Psychiatrische Epidemiologic, p. 135, (Springer, Berlin 1978)Google Scholar
  4. 4.
    Kielholz, P. (Ed.): The general practitioner and his depressed patients (H. Huber, Berne/Stuttgart/Vienna 1981)Google Scholar
  5. 5.
    Kielholz, P., Poldinger, W., Adams, C., Die larvierte Depression (Deutscher Aerzte-Verlag, Köln 1981)Google Scholar
  6. 6.
    Kielholz, P., Terzani, S., Gastpar, M., Behandlung der therapie- resistenten Depressionen. Dtsch. med. Uschr. 103, 241, 1978CrossRefGoogle Scholar
  7. 7.
    Gastpar, M.,Hobi, V., Pöldinger, W., Goldsmith, S., Maly, V., Schmidlin, P., A placebo-controlled comparative study of the combined effects of oxprenolol and clomipramine in depressed patients. Internat. Pharmacopsychiatry 15, 24, 1980Google Scholar
  8. 8.
    Helmchen, H., Enquiries on depression in everyday practice. Results of the enquiry in the German Federal Republic and Berlin. In Kielholz, P. (Ed.): Depression in everyday practice (H. Huber, Berne/Stuttgart/Vienna 1974), p. 137Google Scholar
  9. 9.
    Pichot, P., Hakim, C., The treatment of depression. In Kielholz, P. (Ed.): loc. cit. 8, p. 71Google Scholar
  10. 10.
    Pöldinger, W.: Fortschritte in der Depressionsbehandlung. Der informierte Arzt, Jg. 9, Nr. 9, p. 17, 1981Google Scholar
  11. 11.
    Wirz-Justice, A.: Biochemical studies in depression. Theoretical and therapeutic potential of indoleamine precursors. Neuropsycho- bio. 94, 199, 1977CrossRefGoogle Scholar

Copyright information

© Plenum Press, New York 1985

Authors and Affiliations

  • Paul Kielholz
    • 1
  1. 1.University Psychiatric ClinicBaselSwitzerland

Personalised recommendations